Monica Todoerti
Pavia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.
Journal: Autoimmunity reviews
Published: August 06, 2018
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts.
Journal: Autoimmunity reviews
Published: July 09, 2018
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.
Journal: Modern rheumatology
Published: September 08, 2017
One year in review 2017: novelties in the treatment of rheumatoid arthritis.
Journal: Clinical and experimental rheumatology
Published: August 14, 2017
20 years of experience with tumour necrosis factor inhibitors: what have we learned?
Journal: Rheumatology (Oxford, England)
Published: August 11, 2017
Randomized controlled trials and real-world data: differences and similarities to untangle literature data.
Journal: Rheumatology (Oxford, England)
Published: August 11, 2017
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus.
Journal: Rheumatology (Oxford, England)
Published: August 11, 2017
Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors.
Journal: Arthritis research & therapy
Published: July 30, 2016
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study.
Journal: The Journal of rheumatology
Published: January 09, 2016
Switching from Intravenous to Subcutaneous Formulation of Abatacept: Different Results in a Series of 21 Patients.
Journal: The Journal of rheumatology
Published: October 03, 2015
Oral low-dose glucocorticoids should be included in any recommendation for the use of non-biologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis.
Journal: Neuroimmunomodulation
Published: September 18, 2014
Last Updated: 09/26/2026